Don't miss these live LC & GC educational webinars from Agilent!

  Don't miss these live LC & GC educational webinars from Agilent! Hear from our ...

October 18, 2021 | Monday | News
Indian firm Intas Pharma makes breakthrough in antifungal therapy domain

Intas Pharmaceuticals, based in India, has made a progressive breakthrough in the Antifungal Therapy domain with th...

October 13, 2021 | Wednesday | News
India develops catalytic technology for sustainable production of chiral APIs

India is heavily dependent on importing (~85%) Active Pharmaceutical Ingredients (APIs), and a significant proportion of...

October 7, 2021 | Thursday | News
Merck launches excipient technology platform for protein-based therapeutics

The Life Science business of Merck has launched a new Viscosity Reduction Excipient Platform to reduce the viscosity and...

October 5, 2021 | Tuesday | News
China sets ambitious biomedical goals at Binhai

The Binhai New Area in North China's port city of Tianjin has gathered together more than 1,500 biom...

October 1, 2021 | Friday | News
China focuses on mRNA vaccine R&D and industrialisation

Jiangsu Recbio Technology and Shenzhen Rhegen Biotechnology have recently signed a joint venture agreement to establish ...

September 30, 2021 | Thursday | News
Singapore approves an innovative medication for patients with high cholesterol

Singapore has approved Leqvio® (inclisiran) from Novartis for the treatment of adults with hypercholesterolemia...

September 29, 2021 | Wednesday | News
AstraZeneca revolutionizes health experiences through unique partnerships

The first of two AstraZeneca events with Slush brought together global health tech innovators and diverse patient perspe...

September 27, 2021 | Monday | Company results
Japan approves first and only antibody-drug conjugate (ADC) to treat Urothelial Cancer

Astellas Pharma Inc. and Seagen Inc. announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved P...

September 27, 2021 | Monday | News
Vetter chalks long-term sustainability strategy to become carbon neutral

Contract Development and Manufacturing Organization (CDMO), Vetter is ensuring that all its sites are climate-neutral an...

September 24, 2021 | Friday | News
AstraZeneca inks deal worth $195 M for RNA-based therapeutics

AstraZeneca has reached an agreement to collaborate with VaxEquity for the discovery, development and commercialisastion...

September 23, 2021 | Thursday | News
Takeda invests $14 M to expand first ‘Zero Carbon Emissions' biotech unit in Singapore

Takeda Pharmaceutical building is preparing to follow the Singapore Green Mark Zero Energy certification scheme fir...

September 24, 2021 | Friday | News
Japan's Takeda Pharma picks new partners to help strengthen health systems in LMICs

Japanese firm Takeda Pharmaceutical has announced the addition of four partnerships to its Global Corporate So...

September 23, 2021 | Thursday | News
Singapore approves new therapy to treat advanced small cell lung cancer

Patients in Singapore with an aggressive form of lung cancer (metastatic small cell lung cancer) can now acces...

September 22, 2021 | Wednesday | News
Global Investors invest in Indonesian biopharmaceutical firm to boost cross-border pharma trade

PT Etana Biotechnologies Indonesia (Etana) has secured a new round of investment led by Legend Capital along with I...

September 15, 2021 | Wednesday | News
Kyowa Kirin addresses sepsis-associated acute kidney injury in Japanese population

The Netherlands based AM-Pharma B.V. and Japanese firm Kyowa Kirin have entered into an exclusive license agre...

September 14, 2021 | Tuesday | News
China's Clover Biopharma to launch protein-based COVID-19 vaccine by 2021-end

China-based Clover Biopharmaceuticals has announced that its wholly-owned subsidiary, Zhejiang Clover Biopharmaceut...

September 13, 2021 | Monday | News
Japan buys 150 M doses of Novavax COVID-19 vaccine

Takeda Pharmaceutical has announced that the Government of Japan’s Ministry of Health, Labour and Welfare (MH...

September 8, 2021 | Wednesday | News
Japan lays focus on early detection of heart diseases

Japanese firms Astellas Pharma Inc., Nitto Denko Corporation, and M. Heart Co., have announced that the three companies ...

September 6, 2021 | Monday | News
Indian firm Lupin inks partnership with TB alliance to address drug resistance

US headquartered TB Alliance has granted Indian pharma firm Lupin, a non-exclusive license to manufacture the anti-TB dr...

September 6, 2021 | Monday | News
Japan's Fujifilm sells radiopharma biz to PeptiDream for 30.5 billion yen

Japan-based Fujifilm Corporation has announced the transfer of the radiopharmaceutical business of Fujifilm Toyama Chemi...

September 3, 2021 | Friday | News
Cryoport, Mitsubishi Logistics Corp to bring temperature-controlled supply chain solutions to APAC region

Cryoport, a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences inc...

August 26, 2021 | Thursday | News
Wockhardt Bio partners with China-based Jemincare for pneumonia drug

Wockhardt Bio, a subsidiary of Wockhardt, a leader in the discovery of novel antibiotics and Jiangxi Jemincare Group Com...

August 26, 2021 | Thursday | News
Chinese pharma to commercialize Proxalutamide for COVID-19 treatment in Indonesia

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biologica...

August 26, 2021 | Thursday | News
J&J gives data to support boosting its single-shot COVID-19 vaccine

Johnson & Johnson (J&J) has announced data supporting the use of its COVID-19 vaccine as a booster shot for...

August 25, 2021 | Wednesday | News